2001November 26, 2001Maxygen Announces Issuance of Patent Covering Methods of Template-Based Recombination to Produce Chimeric Genes November 13, 2001Maxygen Reports Strong Third Quarter 2001 Financial and Operating Results November 12, 2001Novozymes and Maxygen Announce Advancement of Two Additional Product Candidates November 12, 2001Maxygen Delivers Two Product Candidates for Development November 7, 2001Maxygen Reiterates Press Release and Makes Available Arbitration Award November 5, 2001Maxygen and Aventis Pasteur Enter Strategic Alliance to Develop Improved Vaccines November 5, 2001Arbitrator Awards Maxygen Sweeping Remedies in Ruling Against Enchira Biotechnology October 9, 2001Maxygen Announces Advancement of Human Therapeutics Candidates October 8, 2001Maxygen Announces Grant of First European Patents October 3, 2001Maxygen Awarded $3.7 Million USAID Cooperative Grant to develop Malaria Vaccine September 26, 2001Maxygen Appoints Alan Shaw, PhD., President of Chemicals Division September 18, 2001Maxygen Creates Novel Protein Activity for New Market Opportunities September 5, 2001InterMune and Maxygen Form Collaboration to Develop Next-Generation Interferon Gamma Products August 14, 2001Maxygen Reports Second Quarter 2001 Financial Results July 20, 2001Maxygen Appoints Dr. Ernest Mario to its Board of Directors July 12, 2001Maxygen Announces Improved Financial outlook May 8, 2001Maxygen Reports First Quarter 2001 Financial Results April 12, 2001Maxygen Appoints John G. Curd, M.D., Senior Vice President, Clinical Development March 8, 2001Maxygen Announces Victory in Arbitration with Enchira Biotechnology February 20, 2001Maxygen and The International AIDS Vaccine Initiative Enter Agreement to Develop Novel Vaccines Against HIV February 13, 2001Maxygen Reports Fourth Quarter and Year End 2000 Financial Results February 12, 2001Maxygen Announces New Patent Covering Use of Mutagenesis with Recombination to Produce Chimeric Genes February 9, 2001Maxygen and Alk-Abello form $80 Million Strategic Alliance to Develop Next-Generation Allergy Treatments January 29, 2001Maxygen Announces Issuance of Additional patent Covering Methods of Gene Recombination Using Single-Stranded Nucleic Acid Templates January 16, 2001Maxygen Expands Senior Management Team January 8, 2001Maxygen Announces Issuance of Additional Patents Covering Methods of Producing Chimeric Genes
Return to News
|
